{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:28:30Z","timestamp":1783571310945,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20194Y0242"],"award-info":[{"award-number":["20194Y0242"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00586-023-07985-x","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:02:25Z","timestamp":1698073345000},"page":"4362-4376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does primary tumor resection improve survival for patients with sarcomas of pelvic bones, sacrum, and coccyx who have metastasis at diagnosis ?"],"prefix":"10.1007","volume":"32","author":[{"given":"Xianglin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wending","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"7985_CR1","unstructured":"American Cancer Society, Cancer Stat Facts: Bone and Joint Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/bones.html."},{"issue":"21","key":"7985_CR2","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.3390\/cancers13215381","volume":"13","author":"X Hu","year":"2021","unstructured":"Hu X, Deng K, Ye H, Sun Z, Huang W, Sun Y, Yan W (2021) Trends in tumor site-specific survival of bone sarcomas from 1980 to 2018: a surveillance, epidemiology and end results-based study. Cancers (Basel) 13(21):5381","journal-title":"Cancers (Basel)"},{"issue":"5","key":"7985_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1586\/14737140.2016.1168697","volume":"16","author":"C Meazza","year":"2016","unstructured":"Meazza C, Scanagatta P (2016) Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev Anticancer Ther 16(5):543\u2013556","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"7985_CR4","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.3928\/01477447-20200721-05","volume":"43","author":"S Tsukamoto","year":"2020","unstructured":"Tsukamoto S, Errani C, Angelini A, Mavrogenis AF (2020) Current treatment considerations for osteosarcoma metastatic at presentation. Orthopedics 43(5):e345\u2013e358","journal-title":"Orthopedics"},{"issue":"10","key":"7985_CR5","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1097\/CORR.0000000000001361","volume":"478","author":"AT Malik","year":"2020","unstructured":"Malik AT, Alexander JH, Mayerson JL, Khan SN, Scharschmidt TJ (2020) Is surgical resection of the primary site associated with an improved overall survival for patients with primary malignant bone tumors who have metastatic disease at presentation? Clin Orthop Relat Res 478(10):2284\u20132295","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"7985_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/CORR.0000000000000632","volume":"477","author":"K Song","year":"2019","unstructured":"Song K, Song J, Chen F, Lin K, Ma X, Jiang J (2019) Does resection of the primary tumor improve survival in patients with metastatic chondrosarcoma? Clin Orthop Relat Res 477(3):573\u2013583","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"7985_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/jjco\/hyaa204","volume":"51","author":"L Zhang","year":"2021","unstructured":"Zhang L, Akiyama T, Fukushima T, Iwata S, Takeshita K, Kawai A, Tanaka S, Kobayashi H (2021) Surgical resection of the primary lesion for osteosarcoma patients with metastasis at initial diagnosis. Jpn J Clin Oncol 51(3):416\u2013423","journal-title":"Jpn J Clin Oncol"},{"issue":"25","key":"7985_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.12659\/MSM.913338","volume":"16","author":"Y Ren","year":"2019","unstructured":"Ren Y, Zhang Z, Shang L, You X (2019) Surgical resection of primary ewing\u2019s sarcoma of bone improves overall survival in patients presenting with metastasis. Med Sci Monit 16(25):1254\u20131262","journal-title":"Med Sci Monit"},{"issue":"1","key":"7985_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.21873\/invivo.12269","volume":"35","author":"C Minichsdorfer","year":"2021","unstructured":"Minichsdorfer C, Steinbrecher O, K\u00d6lz M, Schmid M, Raderer M, Brodowicz T, Lamm W (2021) Adolescents and young adults (ayas) with initially localized and metastatic bone sarcomas: a retrospective single center analysis of side effect management. In Vivo 35(1):385\u2013391","journal-title":"In Vivo"},{"issue":"4","key":"7985_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1158\/1541-7786.MCR-18-0620","volume":"17","author":"SW Brady","year":"2019","unstructured":"Brady SW, Ma X, Bahrami A, Satas G, Wu G, Newman S, Rusch M, Putnam DK, Mulder HL, Yergeau DA, Edmonson MN, Easton J, Alexandrov LB, Chen X, Mardis ER, Wilson RK, Downing JR, Pappo AS, Raphael BJ, Dyer MA, Zhang J (2019) The clonal evolution of metastatic osteosarcoma as shaped by cisplatin treatment. Mol Cancer Res 17(4):895\u2013906","journal-title":"Mol Cancer Res"},{"issue":"7","key":"7985_CR11","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.3390\/ijms23073817","volume":"23","author":"MA Harris","year":"2022","unstructured":"Harris MA, Hawkins CJ (2022) Recent and ongoing research into metastatic osteosarcoma treatments. Int J Mol Sci 23(7):3817","journal-title":"Int J Mol Sci"},{"issue":"17","key":"7985_CR12","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/cncr.32118","volume":"125","author":"HG Lyu","year":"2019","unstructured":"Lyu HG, Haider AH, Landman AB, Raut CP (2019) The opportunities and shortcomings of using big data and national databases for sarcoma research. Cancer 125(17):2926\u20132934","journal-title":"Cancer"},{"issue":"7","key":"7985_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1158\/1055-9965.EPI-20-1796","volume":"30","author":"L Gallicchio","year":"2021","unstructured":"Gallicchio L, Daee DL, Rotunno M, Barajas R, Fagan S, Carrick DM, Divi RL, Filipski KK, Freedman AN, Gillanders EM, Lam TK, Martin DN, Rogers S, Verma M, Nelson SA (2021) Epidemiologic research of rare cancers: trends, resources, and challenges. Cancer Epidemiol Biomark Prev 30(7):1305\u20131311","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2021","key":"7985_CR14","first-page":"8027314","volume":"6","author":"JM Brown","year":"2021","unstructured":"Brown JM, Matichak D, Rakoczy K, Groundland J (2021) Osteosarcoma of the pelvis: clinical presentation and overall survival. Sarcoma 6(2021):8027314","journal-title":"Sarcoma"},{"issue":"4","key":"7985_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ijc.33823","volume":"150","author":"E Lavit","year":"2022","unstructured":"Lavit E, Aldea M, Piperno-Neumann S, Firmin N, Italiano A, Isambert N, Kurtz JE, Delcambre C, Lebrun V, Soibinet-Oudot P, Chevreau C, Bompas E, Le Maignan C, Boudou-Rouquette P, Le Cesne A, Mancini J, Blay JY, Duffaud F (2022) Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: a retrospective series of the French sarcoma group. Int J Cancer 150(4):645\u2013653","journal-title":"Int J Cancer"},{"issue":"2","key":"7985_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/cancers14020360","volume":"14","author":"GA Odri","year":"2022","unstructured":"Odri GA, Tchicaya-Bouanga J, Yoon DJY, Modrowski D (2022) Metastatic progression of osteosarcomas: a review of current knowledge of environmental versus oncogenic drivers. Cancers (Basel) 14(2):360","journal-title":"Cancers (Basel)"},{"issue":"5","key":"7985_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/14737140.2020.1760848","volume":"20","author":"C Meazza","year":"2020","unstructured":"Meazza C, Bastoni S, Scanagatta P (2020) What is the best clinical approach to recurrent\/refractory osteosarcoma? Expert Rev Anticancer Ther 20(5):415\u2013428","journal-title":"Expert Rev Anticancer Ther"},{"key":"7985_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.101993","volume":"86","author":"A Grothey","year":"2020","unstructured":"Grothey A, Blay JY, Pavlakis N, Yoshino T, Bruix J (2020) Evolving role of regorafenib for the treatment of advanced cancers. Cancer Treat Rev 86:101993","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"7985_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S1470-2045(18)30742-3","volume":"20","author":"F Duffaud","year":"2019","unstructured":"Duffaud F, Mir O, Boudou-Rouquette P, Piperno-Neumann S, Penel N, Bompas E, Delcambre C, Kalbacher E, Italiano A, Collard O, Chevreau C, Saada E, Isambert N, Delaye J, Schiffler C, Bouvier C, Vidal V, Chabaud S, Blay JY (2019) Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncol 20(1):120\u2013133","journal-title":"Lancet Oncol"},{"issue":"16","key":"7985_CR20","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1200\/JCO.18.02374","volume":"37","author":"LE Davis","year":"2019","unstructured":"Davis LE, Bolejack V, Ryan CW, Ganjoo KN, Loggers ET, Chawla S, Agulnik M, Livingston MB, Reed D, Keedy V, Rushing D, Okuno S, Reinke DK, Riedel RF, Attia S, Mascarenhas L, Maki RG (2019) Randomized double-blind phase ii study of regorafenib in patients with metastatic osteosarcoma. J Clin Oncol 37(16):1424\u20131431","journal-title":"J Clin Oncol"},{"issue":"8","key":"7985_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11864-020-00760-w","volume":"21","author":"F Duffaud","year":"2020","unstructured":"Duffaud F (2020) Role of TKI for metastatic osteogenic sarcoma. Curr Treat Options Oncol 21(8):65","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"7985_CR22","doi-asserted-by":"publisher","first-page":"e27251","DOI":"10.1002\/pbc.27251","volume":"65","author":"J Worch","year":"2018","unstructured":"Worch J, Ranft A, DuBois SG, Paulussen M, Juergens H, Dirksen U (2018) Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma. Pediatr Blood Cancer 65(9):e27251","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"7985_CR23","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.3390\/jcm10163627","volume":"10","author":"P Jagodzi\u0144ska-Mucha","year":"2021","unstructured":"Jagodzi\u0144ska-Mucha P, Raciborska A, Kose\u0142a-Paterczyk H, Kozak K, Bilska K, \u015awitaj T, Falkowski S, Dawidowska A, Rutkowski P, \u0141ugowska I (2021) Age as a prognostic factor in patients with ewing sarcoma-the polish sarcoma group experience. J Clin Med 10(16):3627","journal-title":"J Clin Med"},{"issue":"6","key":"7985_CR24","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3390\/cancers14061456","volume":"14","author":"SE Bosma","year":"2022","unstructured":"Bosma SE, van der Heijden L, Sierrases\u00famaga L, Merks HJHM, Haveman LM, van de Sande MAJ, San-Juli\u00e1n M (2022) What do we know about survival in skeletally premature children aged 0 to 10 years with ewing sarcoma? a multicenter 10-year follow-up study in 60 patients. Cancers (Basel) 14(6):1456","journal-title":"Cancers (Basel)"},{"issue":"3","key":"7985_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S1470-2045(19)30825-3","volume":"21","author":"A Italiano","year":"2020","unstructured":"Italiano A, Mir O, Mathoulin-Pelissier S, Penel N, Piperno-Neumann S, Bompas E, Chevreau C, Duffaud F, Entz-Werl\u00e9 N, Saada E, Ray-Coquard I, Lervat C, Gaspar N, Marec-Berard P, Pacquement H, Wright J, Toulmonde M, Bessede A, Crombe A, Kind M, Bellera C, Blay JY (2020) Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial. Lancet Oncol 21(3):446\u2013455","journal-title":"Lancet Oncol"},{"issue":"3","key":"7985_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1470-2045(20)30004-8","volume":"21","author":"F Fagioli","year":"2020","unstructured":"Fagioli F, Tirtei E (2020) Cabozantinib: a new perspective for advanced bone sarcoma. Lancet Oncol 21(3):331\u2013332","journal-title":"Lancet Oncol"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-023-07985-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00586-023-07985-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-023-07985-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T22:07:35Z","timestamp":1700604455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00586-023-07985-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["7985"],"URL":"https:\/\/doi.org\/10.1007\/s00586-023-07985-x","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"21 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was waived for this study because of the de-identified information of the patients in the public Surveillance, Epidemiology, and End Results Program.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors read and approved the submission and had consented for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}